Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep;56(3):308-328.
doi: 10.3947/ic.2024.0038. Epub 2024 Aug 2.

Guidelines for Antibacterial Treatment of Carbapenem-Resistant Enterobacterales Infections

Se Yoon Park #  1 , Yae Jee Baek #  2 , Jung Ho Kim  3 , Hye Seong  4 , Bongyoung Kim  1   5 , Yong Chan Kim  3   6 , Jin Gu Yoon  4 , Namwoo Heo  6 , Song Mi Moon  7 , Young Ah Kim  8 , Joon Young Song  4 , Jun Yong Choi  3 , Yoon Soo Park  3   9 ; Korean Society for Antimicrobial Therapy
Affiliations
Review

Guidelines for Antibacterial Treatment of Carbapenem-Resistant Enterobacterales Infections

Se Yoon Park et al. Infect Chemother. 2024 Sep.

Abstract

This guideline aims to promote the prudent use of antibacterial agents for managing carbapenem-resistant Enterobacterales (CRE) infections in clinical practice in Korea. The general section encompasses recommendations for the management of common CRE infections and diagnostics, whereas each specific section is structured with key questions that are focused on antibacterial agents and disease-specific approaches. This guideline covers both currently available and upcoming antibacterial agents in Korea.

Keywords: Antibacterial agents; Carbapenem-resistant Enterobacterales; Practice guideline.

PubMed Disclaimer

Conflict of interest statement

BK is associate editor of Infect Chemother; JYC and JYS editorial board of Infect Chemother; however, they did not involve in the peer reviewer selection, evaluation, and decision process of this article. Otherwise, no potential conflicts of interest relevant to this article was reported.

References

    1. Centers for Disease Control and Prevention (CDC) Facility guidance for control of carbapenem-resistant Enterobacteiaceae (CRE): November 2015 update-CRE toolkit. [Accessed 30 March 2024]. Available at: https://stacks.cdc.gov/view/cdc/79104.
    1. World Health Organization (WHO) Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities. [Accessed 30 March 2024]. Available at: https://www.who.int/publications/i/item/9789241550178. - PubMed
    1. Korea Disease Control and Prevention Agency (KDCA) National antibiotic-resistant bacteria surveillance annual Report. 2021. [Accessed 30 March 2024]. Available at: https://nih.go.kr/nohas/common/board/readBoardView.do.
    1. Im J, Shim J, Lee H, Hyeon J, Lee S, Park S. Characteristics of Carbapenem-resistant Enterobacteriaceae (CRE) in the Republic of Korea, 2022. Public Health Wkly Rep. 2024;17:115–127.
    1. Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Infectious Diseases Society of America guidance on the treatment of extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa) Clin Infect Dis. 2021;72:e169–e183. - PubMed